Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US considers doubling AIDS funding plan to $30bn:

This article was originally published in Clinica

Executive Summary

The Global Fund to Fight AIDS, Tuberculosis and Malaria has welcomed US proposals to extend the President's Emergency Plan for AIDS Relief (PEPFAR) for a further five years, doubling the fund to $30bn. The timing is seen as particularly important as setting an international funding commitment standard ahead of the G8 summit. Only 2.2 million of the 6 million people with AIDS in the developing world receive treatment, says the Global Fund. For the World Health Organization, however, there is a far greater diagnostic need that relies on intensifying community-wide screening, and has launched an initiative to tackle this.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048806

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel